Advertisement

---

INTERMUNE, INC.

InterMune To Present At JMP Securities Healthcare Conference

[2013-07-02] -


InterMune Announces Publication of Pricing and Reimbursement Conditions for Esbriet® (pirfenidone) in Italy

[2013-06-14] - -- First approved therapy for IPF patients in Italy will be reimbursed from June 29 --


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers